» Articles » PMID: 11802803

A Statistical Study of Lung Cancer in the Annual of Pathological Autopsy Cases in Japan, from 1958 to 1997, with Reference to Time Trends of Lung Cancer in the World

Overview
Specialty Oncology
Date 2002 Jan 23
PMID 11802803
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Lung cancer cases (66650 males and 20890 females) registered in the Annual of Pathological Autopsy Cases in Japan, between 1958 and 1997, were analyzed with regard to sex, age and histology. They were subdivided into decades (periods I to IV), and compared with the Japanese mortality statistics, with which they were in good correspondence. Although the autopsy rate is decreasing, more than 10% of the total lung cancer deaths in Japan were registered by 1990. Among autopsied cases, the incidence of lung cancer cases increased from 6% to 12% in males and from 3% to 6% in females. From period III, lung cancer in males became the most frequent, and was the second most frequent cancer in females after gastric cancer. As for the histological distribution, adenocarcinoma was the most frequent and squamous cell carcinoma was the next most frequent in both sexes. Recently, a significant increase in adenocarcinoma and a significant decrease in squamous cell carcinoma have been observed in both sexes. The peak ages shifted from the 60s to the 70s and a significant rise in the mean ages were observed. The male-to-female ratios and the ratio curves by histological and age group were high for squamous cell carcinoma and small cell carcinoma, while they were low for the total and adenocarcinoma. With the recently acquired data on lung cancer in Asian countries, and from the male-to-female ratios and the status of smoking rates, lung cancer in the world at present was divided into three groups; North America, Europe and Asia. The possibility of one group changing to resemble another and of groups converging in the near future is suggested.

Citing Articles

Efficacy and safety of carboplatin and etoposide in older extensive-stage small-cell lung cancer patients with a poor performance status.

Mamesaya N, Kodama H, Iida Y, Kobayashi H, Ko R, Wakuda K Thorac Cancer. 2023; 14(9):805-814.

PMID: 36700290 PMC: 10040279. DOI: 10.1111/1759-7714.14811.


Impact of Amrubicin Monotherapy as Second-Line Chemotherapy on Outcomes in Elderly Patients with Relapsed Extensive-Disease Small-Cell Lung Cancer.

Igawa S, Ono T, Kasajima M, Manabe H, Fukui T, Mitsufuji H Cancer Manag Res. 2020; 12:4911-4921.

PMID: 32606979 PMC: 7320750. DOI: 10.2147/CMAR.S255552.


The efficacy of amrubicin third-line chemotherapy in patients with relapsed extensive-disease small-cell lung cancer: A retrospective and historical study in a single institute.

Sonehara K, Tateishi K, Fukushima T, Komatsu M, Yamamoto H, Koizumi T Thorac Cancer. 2019; 10(9):1805-1811.

PMID: 31350820 PMC: 6718015. DOI: 10.1111/1759-7714.13150.


Sex Difference of Radiation Response in Occupational and Accidental Exposure.

Narendran N, Luzhna L, Kovalchuk O Front Genet. 2019; 10:260.

PMID: 31130979 PMC: 6509159. DOI: 10.3389/fgene.2019.00260.


Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancer.

Shirasawa M, Fukui T, Kusuhara S, Harada S, Nishinarita N, Hiyoshi Y PLoS One. 2019; 14(4):e0214599.

PMID: 31002722 PMC: 6474590. DOI: 10.1371/journal.pone.0214599.


References
1.
Roberts W . The autopsy: its decline and a suggestion for its revival. N Engl J Med. 1978; 299(7):332-8. DOI: 10.1056/NEJM197808172990704. View

2.
Silverberg S . The autopsy and cancer. Arch Pathol Lab Med. 1984; 108(6):476-8. View

3.
Thun M, Lally C, Flannery J, Calle E, Flanders W, Heath Jr C . Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst. 1997; 89(21):1580-6. DOI: 10.1093/jnci/89.21.1580. View

4.
Morabia A, Wynder E . Cigarette smoking and lung cancer cell types. Cancer. 1991; 68(9):2074-8. DOI: 10.1002/1097-0142(19911101)68:9<2074::aid-cncr2820680939>3.0.co;2-x. View

5.
Zang E, Wynder E . Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst. 1996; 88(3-4):183-92. DOI: 10.1093/jnci/88.3-4.183. View